LONDON – Blocking signals from immune cells could provide a way to prevent melanoma cells from becoming resistant to the latest highly promising therapies. A new study has shown that the cytokine (chemical messenger) TNF-alpha acts as a growth factor for melanoma cells. Not only that, this cytokine attracts additional immune cells to the tumor, which in turn release more TNF-alpha.